With the continuous evaluation of generic drug consistency and the implementation of the policy of joint review and approval of original and auxiliary packaging, pharmaceutical companies have taken responsibility for improving product quality independently and greatly enhanced the subjective initiative of active pharmaceutical ingredient companies. The API market in China will already burst with new vitality with the implementation of the joint review and approval system. Represented by China National Pharmaceutical Group, Tianyao Group, Shangyao Group, Qilu Pharmaceutical, Northeast Pharmaceutical, Shandong Xinhua, Lizhu Group, Huahai Pharmaceutical, Haizheng Pharmaceutical, Chuangnuo Pharmaceutical, Hengxin Pharmaceutical, Disha Pharmaceutical, and Erkang Pharmaceutical, the "traditional powerhouses" of the Chinese pharmaceutical industry will gather in Xi'an with their traditional advantageous products and the latest research and development of new varieties, together with more than 1000 excellent Chinese API companies, under the theme of "Original Dream, Original Aspiration, Material Creation for the Future", to unleash new vitality in the pharmaceutical raw material exhibition located in Hall 3/Hall 5.

Exhibition content: Pharmaceutical raw materials, pharmaceutical excipients, natural extracts, chemical reagents, intermediates, fine chemical raw materials, important raw materials, food raw materials and additives, animal medicine raw materials, feed raw materials and additives, health product raw materials and additives, biotechnology, pharmaceutical research and development services, contract customized production services, registration and pharmaceutical services, training services